natgillin/translations-raw huggingface dataset:
The substance 1,2-benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters, meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation.
Snov 1,2-benzendikarboksilna kislina, di-C7–11-razvejani in nerazvejani alkilni estri, izpolnjuje merila za razvrstitev kot strupena za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(c) navedene uredbe.
The substance 1,2-benzenedicarboxylic acid, dipentylester, branched and linear, meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation.
Snov 1,2-benzendikarboksilna kislina, dipentilester, razvejan in nerazvejan, izpolnjuje merila za razvrstitev kot strupena za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(c) navedene uredbe.
The substance bis(2-methoxyethyl) phthalate meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation.
Snov bis(2-metoksietil) ftalat izpolnjuje merila za razvrstitev kot strupena za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(c) navedene uredbe.
The substance dipentylphthalate meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation.
Snov dipentilftalat izpolnjuje merila za razvrstitev kot strupena za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(c) navedene uredbe.
The substance N-pentyl-isopentylphthalate meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation.
Snov N-pentil-izopentilftalat izpolnjuje merila za razvrstitev kot strupena za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(c) navedene uredbe.
When containing a certain percentage of benzo[a]pyrene, the substance anthracene oil meets the criteria for classification as carcinogenic (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(a) of that Regulation.
Snov antracensko olje, ki vsebuje določen odstotek benzo[a]pirena, izpolnjuje merila za razvrstitev kot rakotvorna (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(a) navedene uredbe.
The substance is also persistent, bioaccumulative and toxic, as well as very persistent and very bioaccumulative in accordance with the criteria set out in Annex XIII to Regulation (EC) No 1907/2006 and therefore meets the criteria for inclusion in Annex XIV to that Regulation set out in Article 57(d) and (e) of that Regulation.
Za snov v skladu z merili iz Priloge XIII k Uredbi (ES) št. 1907/2006 prav tako velja, da je obstojna, se kopiči v organizmih in je strupena ter da je zelo obstojna in se zelo lahko kopiči v organizmih, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k navedeni uredbi iz člena 57(d) in (e) navedene uredbe.
The substance pitch, coal tar, high temp. meets the criteria for classification as carcinogenic (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(a) of that Regulation.
Snov smola, premogov katran, visokotemp., izpolnjuje merila za razvrstitev kot rakotvorna (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(a) navedene uredbe.
The substance is also persistent, bioccumulative and toxic, as well as very persistent and very bioaccumulative in accordance with the criteria set out in Annex XIII to Regulation (EC) No 1907/2006 and therefore meets the criteria for inclusion in Annex XIV to that Regulation set out in Article 57(d) and (e) of that Regulation.
Za snov v skladu z merili iz Priloge XIII k Uredbi (ES) št. 1907/2006 prav tako velja, da je obstojna, se kopiči v organizmih in je strupena ter da je zelo obstojna in se zelo lahko kopiči v organizmih, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k navedeni uredbi iz člena 57(d) in (e) navedene uredbe.
The substance group 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (covering well-defined substances and substances of unknown or variable composition, complex reaction products or biological materials (‘UVCB substances’), polymers and homologues) are substances which through their degradation have endocrine disrupting properties for which there is scientific evidence of probable serious effects to the environment.
Skupino snovi 4-(1,1,3,3-tetrametilbutil)fenol, etoksiliran (ki zajema natančno opredeljene snovi in snovi z neznano ali spremenljivo sestavo, kompleksne reakcijske produkte ali biološke materiale („snovi UVCB“), polimere in homologe) sestavljajo snovi, ki z razgradnjo dobijo lastnosti endokrinih motilcev, za katere obstajajo znanstveni dokazi o morebitnih resnih učinkih na okolje.
As such, they give rise to an equivalent level of concern to those of other substances listed in points (a) to (e) of Article 57 of Regulation (EC) No 1907/2006 and, therefore, meet the criteria for inclusion in Annex XIV to that Regulation set out in Article 57(f) of that Regulation.
Kot take vzbujajo zaskrbljenost, ki je enakovredna zaskrbljenosti pri drugih snoveh iz točk (a) do (e) člena 57 Uredbe (ES) št. 1907/2006, zato izpolnjujejo tudi merila za vključitev v Prilogo XIV k navedeni uredbi iz člena 57(f) navedene uredbe.
The substance group 4-nonylphenol, branched and linear, ethoxylated (including substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof), are substances which through their degradation have endocrine disrupting properties for which there is scientific evidence of probable serious effects to the environment.
Skupino snovi 4-nonilfenol, razvejan in nerazvejan, etoksiliran (ki vključuje snovi z nerazvejano in/ali razvejano alkilno verigo z 9 ogljikovimi atomi, ki se na 4. mestu kovalentno veže na fenol, etoksiliran, ki zajemajo snovi UVCB in natančno opredeljene snovi, polimere in homologe, ki vključujejo kateri koli posamezni izomer in/ali njihovo kombinacijo) sestavljajo snovi, ki z razgradnjo dobijo lastnosti endokrinih motilcev, za katere obstajajo znanstveni dokazi o morebitnih resnih učinkih na okolje.
As such, they give rise to an equivalent level of concern to those of other substances listed in points (a) to (e) of Article 57 of Regulation (EC) No 1907/2006 and, therefore, meet the criteria for inclusion in Annex XIV to that Regulation set out in Article 57(f) of that Regulation.
Kot take vzbujajo zaskrbljenost, ki je enakovredna zaskrbljenosti pri drugih snoveh iz točk (a) do (e) člena 57 Uredbe (ES) št. 1907/2006, zato izpolnjujejo tudi merila za vključitev v Prilogo XIV k navedeni uredbi iz člena 57(f) navedene uredbe.
Those substances have been identified and included in the candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006.
Navedene snovi so bile identificirane in vključene na seznam snovi v skladu s členom 59 Uredbe (ES) št. 1907/2006.
They have furthermore been prioritised for inclusion in Annex XIV to Regulation (EC) No 1907/2006 by the European Chemicals Agency (‘the Agency’) in its recommendations of 6 February 2014 [3] and 1 July 2015 [4], in accordance with Article 58 of that Regulation.
Evropska agencija za kemikalije (v nadaljnjem besedilu: Agencija) jim je v priporočilih z dne 6. februarja 2014 [3] in 1. julija 2015 [4] v skladu s členom 58 Uredbe (ES) št. 1907/2006 prav tako dala prednost za vključitev v Prilogo XIV k navedeni uredbi.
In addition, the Commission has received information on socioeconomic impacts provided in the numerous stakeholder submissions after receipt of the Agency's fifth recommendation or provided through a public consultation conducted in parallel with the Agency's public consultation on its draft sixth recommendation.
Poleg tega je Komisija prejela informacije o socialno-ekonomskih vplivih, zajete v številnih prispevkih zainteresiranih strani po prejemu petega priporočila Agencije, ali z javnega posvetovanja, ki je potekalo vzporedno z javnim posvetovanjem Agencije o njenem osnutku šestega priporočila.
Notwithstanding the information received, it is appropriate to include those substances in that Annex.
Ne glede na prejete informacije je navedene snovi primerno vključiti v navedeno prilogo.
It is appropriate to indicate the dates referred to in Article 58(1)(c)(ii) of Regulation (EC) No 1907/2006 in line with the Agency's recommendations of 6 February 2014 and of 1 July 2015.
Primerno je navesti datume iz člena 58(1)(c)(ii) Uredbe (ES) št. 1907/2006 v skladu s priporočili Agencije z dne 6. februarja 2014 in 1. julija 2015.
Those dates have been identified on the basis of the estimated time that would be required to prepare an application for the authorisation, taking into account the information available on the different substances and the information received during the public consultation carried out in accordance with Article 58(4) of Regulation (EC) No 1907/2006.
Navedeni datumi so bili določeni glede na predviden čas, potreben za pripravo vloge za avtorizacijo, ob upoštevanju razpoložljivih informacij o različnih snoveh in informacij, prejetih v okviru javnega posvetovanja, opravljenega v skladu s členom 58(4) Uredbe (ES) št. 1907/2006.
To that purpose, the Agency's capacity to handle applications in the time provided for in Regulation (EC) No 1907/2006 should also been taken into account, as provided in Article 58(3) of that Regulation.
Za ta namen bi bilo treba upoštevati tudi zmogljivost Agencije za obravnavanje vlog v roku, določenem v Uredbi (ES) št. 1907/2006, kot določa člen 58(3) navedene uredbe.
For each of those substances listed in the Annex to this Regulation there are no reasons why the date referred to in Article 58(1)(c)(i) of Regulation (EC) No 1907/2006 should be set later than 18 months after the date referred to in Article 58(1)(c)(ii) of that Regulation.
Za nobeno od navedenih snovi iz Priloge k tej uredbi ne obstajajo razlogi za določitev datuma iz člena 58(1)(c)(i) Uredbe (ES) št. 1907/2006 več kot 18 mesecev po datumu iz člena 58(1)(c)(ii) navedene uredbe.
Article 58(1)(e) in conjunction with Article 58(2) of Regulation (EC) No 1907/2006 provides for the possibility of exemptions of uses or categories of uses in cases where specific Union legislation imposes minimum requirements relating to the protection of human health or the environment ensuring proper control of the risks.
Člen 58(1)(e) v povezavi s členom 58(2) Uredbe (ES) št. 1907/2006 določa možnost izvzetja uporab ali skupin uporab, kadar posebna zakonodaja Unije določa minimalne zahteve v zvezi z varovanjem zdravja ljudi ali okolja za zagotovitev primernega nadzora tveganj.
On the basis of the information currently available it is not appropriate to set exemptions for product and process orientated research and development.
Na podlagi trenutno razpoložljivih informacij ni primerno določiti izvzetij za v proizvod in proces usmerjene raziskave in razvoj.
On the basis of the information currently available it is not appropriate to set review periods for certain uses.
Na podlagi trenutno razpoložljivih informacij ni primerno določiti obdobij za preverjanje določenih uporab.
In accordance with Article 60(8) of Regulation (EC) No 1907/2006 review periods are to be determined on a case-by-case basis taking into account, inter alia, the risks posed by the uses of the substance, the socioeconomic benefits arising from its use and the analysis of alternatives or any substitution plan submitted for uses for which authorisation is requested.
V skladu s členom 60(8) Uredbe (ES) št. 1907/2006 je treba obdobja za preverjanje določiti za vsak primer posebej, pri čemer se med drugim upoštevajo tveganja, povezana z uporabami snovi, socialno-ekonomske koristi, ki izhajajo iz njene uporabe, in analiza alternativ ali načrt nadomestitve, predložen za uporabe, za katere se zahteva avtorizacija.
In instances where there is no suitable alternative, the risks posed by the use are limited by appropriate and effective risk management measures, and when the benefits arising from the use are expected to be high, as could be the case for uses in the production of medicinal products or medical devices, review periods could be long.
Kadar ni na voljo nobene ustrezne alternative, so tveganja, povezana z uporabo, omejena z ustreznimi in učinkovitimi ukrepi za obvladovanje tveganja, kadar se pričakujejo velike koristi, povezane z uporabo, na primer pri uporabah v proizvodnji zdravil ali medicinskih pripomočkov, pa so obdobja za preverjanje lahko dolga.
In order to avoid the premature obsolescence of articles that are no longer produced after the sunset dates referred to Annex XIV to Regulation (EC) No 1907/2006, some substances (by themselves or in mixtures) included in that Annex need to be available for the production of spare parts for the repair of those articles, where those articles cannot function as intended without those spare parts, as well as where some Annex XIV substances (by themselves or in mixtures) are necessary for the repair of such articles.
Da bi preprečili prezgodnjo zastarelost izdelkov, ki se po datumih poteka iz Priloge XIV k Uredbi (ES) št. 1907/2006 ne proizvajajo več, morajo biti nekatere snovi (same ali v zmeseh) iz navedene priloge na voljo za proizvodnjo nadomestnih delov za popravilo navedenih izdelkov, če navedeni izdelki brez nadomestnih delov ne morejo delovati, kot je bilo predvideno, in če so nekatere snovi (same ali v zmeseh) iz Priloge XIV potrebne za popravilo takih izdelkov.
To that end, applications for authorisation for the use of an Annex XIV substance for the production of such spare parts and for the repair of such articles should be simplified.
V ta namen bi bilo vloge za avtorizacijo za uporabo snovi iz Priloge XIV za proizvodnjo takih nadomestnih delov in popravilo takih izdelkov treba poenostaviti.
The transitional arrangements applicable to the substances concerned by those uses should be extended in order to allow for the adoption of implementing measures for such simplified applications for authorisation.
Prehodne ureditve, ki se uporabljajo za snovi z navedenimi uporabami, bi bilo treba podaljšati, da bi se omogočilo sprejetje izvedbenih ukrepov za take poenostavljene vloge za avtorizacijo.
N,N-Dimethylformamide (DMF) meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation.
N,N-dimetilformamid (DMF) izpolnjuje merila za razvrstitev kot strupen za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(c) navedene uredbe.
It has also been identified and included in the candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006 and prioritised for inclusion in Annex XIV to that Regulation by the Agency's recommendation of 6 February 2014 in accordance with Article 58 of that Regulation.
Agencija je navedeno snov tudi identificirala in vključila na seznam snovi v skladu s členom 59 Uredbe (ES) št. 1907/2006 ter ji v priporočilu z dne 6. februarja 2014 v skladu s členom 58 navedene uredbe dala prednost za vključitev v Prilogo XIV k navedeni uredbi.
DMF has similar intrinsic properties to those of N,N-dimethylacetamide (DMAC) and N-methyl-2-pyrrolidone (NMP) and the three substances may be considered as potential alternatives for some of their major uses.
DMF ima podobne intrinzične lastnosti kot N,N-dimetilacetamid (DMAC) in N-metil-2-pirolidon (NMP) in vse tri snovi se za nekatere pomembnejše uporabe lahko obravnavajo kot morebitne alternative.
NMP is the subject of an on-going restriction procedure in accordance with Article 69 of Regulation (EC) No 1907/2006.
Za NMP trenutno poteka postopek za omejitev v skladu s členom 69 Uredbe (ES) št. 1907/2006.
In view of the similarities of the three substances, both regarding their intrinsic properties and their industrial applications, and in order to ensure a consistent regulatory approach, the Commission considers it appropriate to postpone the decision on the inclusion of DMF in Annex XIV as has already been done for DMAC when the Commission considered the Agency's recommendation of 17 January 2013.
Glede na podobnost navedenih treh snovi, tako glede njihovih intrinzičnih lastnosti kot glede industrijskih uporab, in da se zagotovi usklajen regulativni pristop, Komisija meni, da je odločitev o vključitvi DMF v Prilogo XIV primerno odložiti, tako kot v primeru DMAC, ko je Komisija upoštevala priporočilo Agencije z dne 17. januarja 2013.
Diazene-1,2-dicarboxamide (C,C′-azodi(formamide)) (ADCA) meets the criteria for classification as a respiratory sensitiser (Resp.
Diazen-1,2-dikarboksamid (C,C′-azodi(formamid)) (ADCA) izpolnjuje merila za razvrstitev kot povzročitelj preobčutljivosti dihal (Resp. sens.
Sens.1).
1).
Taking into account all available information about the intrinsic properties of ADCA and about its adverse effects, the Agency concluded that it can be regarded as a substance for which there is scientific evidence of probable serious effects to human health which give rise to an equivalent level of concern to those of other substances listed in points (a) to (e) of Article 57 of Regulation (EC) No 1907/2006 and therefore meets the criteria for inclusion in Annex XIV to that Regulation set out in Article 57(f) of that Regulation.
Ob upoštevanju vseh razpoložljivih informacij o intrinzičnih lastnostih ADCA in njegovih škodljivih učinkih je Agencija ugotovila, da ga je mogoče obravnavati kot snov, za katero obstajajo znanstveni dokazi o morebitnih resnih učinkih na zdravje ljudi, ki vzbujajo zaskrbljenost, ki je enakovredna zaskrbljenosti pri drugih snoveh iz točk (a) do (e) člena 57 Uredbe (ES) št. 1907/2006, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k navedeni uredbi iz člena 57(f) navedene uredbe.
It has also been identified and included in the candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006 and prioritised for inclusion in Annex XIV to that Regulation by the Agency's recommendation of 6 February 2014 in accordance with Article 58 of that Regulation.
Agencija je navedeno snov tudi identificirala in vključila na seznam snovi v skladu s členom 59 Uredbe (ES) št. 1907/2006 ter ji v priporočilu z dne 6. februarja 2014 v skladu s členom 58 navedene uredbe dala prednost za vključitev v Prilogo XIV k navedeni uredbi.
Uses of ADCA are very diverse and concern a broad range of different manufacturing industries, expected to lead to highly complex applications for authorisation.
Uporabe ADCA so zelo raznolike in so povezane s številnimi različnimi predelovalnimi industrijami, zaradi česar so vloge za avtorizacijo lahko zelo zapletene.
As currently the experience for handling authorisation applications covering broad ranges of uses is still limited, it is appropriate to postpone the decision on the inclusion of ADCA in Annex XIV, for the time being.
Ker so trenutno izkušnje z obravnavanjem vlog za avtorizacijo, ki zajemajo širok razpon uporab, še omejene, je odločitev o vključitvi ADCA v Prilogo XIV za zdaj primerno odložiti.
Certain aluminosilicate refractory ceramic fibres (Al-RCF) and zirconia aluminosilicate refractory ceramic fibres (Zr-RCF) meet the criteria for classification as carcinogenic (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meet the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(a) of that Regulation.
Nekatera alumosilikatna refraktorska keramična vlakna (Al-RCF) in cirkonijeva alumosilikatna refraktorska keramična vlakna (Zr-RCF) izpolnjujejo merila za razvrstitev kot rakotvorna (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjujejo tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(a) navedene uredbe.
They have also been identified and included in the candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006 and prioritised for inclusion in Annex XIV to that Regulation by the Agency's recommendation of 6 February 2014 in accordance with Article 58 of that Regulation.
Agencija je navedene snovi tudi identificirala in vključila na seznam snovi v skladu s členom 59 Uredbe (ES) št. 1907/2006 ter jim v priporočilu z dne 6. februarja 2014 v skladu s členom 58 navedene uredbe dala prednost za vključitev v Prilogo XIV k navedeni uredbi.
The actual fibres are manufactured at a very limited number of industrial sites and are in general directly transformed within the same manufacturing process into articles that are subsequently used in a broad range of industrial equipment for high-temperature insulation, which can potentially lead to significant worker exposure.
Vlakna se proizvajajo na zelo redkih industrijskih območjih in se na splošno v istem proizvodnem postopku neposredno pretvorijo v izdelke, ki se nato uporabljajo v različni industrijski opremi za visokotemperaturno izolacijo, kar lahko privede do znatne izpostavljenosti delavcev.
However, the use of articles made of the fibres is not subject to authorisation under Regulation (EC) No 1907/2006.
Vendar pa za uporabo izdelkov iz teh vlaken ni potrebna avtorizacija iz Uredbe (ES) št. 1907/2006.
In order to decide on the most relevant regulatory approach, the Commission considers it appropriate to postpone the decision on the inclusion of Al-RCF and Zr-RCF in Annex XIV to Regulation (EC) No 1907/2006 for the time being.
Da bi se sprejela odločitev o najustreznejšem regulativnem pristopu, Komisija meni, da je odločitev o vključitvi Al-RCF in Zr-RCF v Prilogo XIV k Uredbi (ES) št. 1907/2006 za zdaj primerno odložiti.
Boric acid, disodium tetraborate (anhydrous), diboron trioxide, and tetraboron disodium heptaoxide (hydrate) meet the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meet the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(c) of that Regulation.
Borova kislina, dinatrijev tetraborat (brezvodni), diborov trioksid in tetrabor-dinatrijev heptaoksid (hidrat) izpolnjujejo merila za razvrstitev kot strupeni za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjujejo tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(c) navedene uredbe.